Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents

Appendix C: Panel Roster and Financial Disclosures


Last Updated: September 1, 2014; Last Reviewed: September 1, 2014

Mycobacterium tuberculosis Infection and Disease
Member Financial Disclosure
Company Relationship
Dooley, Kelly Johns Hopkins University ViiV Health Care Research Support
Gandhi, Neel Rollins School of Public Health-Emory University None N/A
Havlir, Diane* University of California, San Francisco Abbot Research Support
Gilead Research Support
Luetkemeyer, Annie University of California, San Francisco Cepheid Research Support
Maartens, Gary University of Cape Town, South Africa None N/A
Meintjes, Graeme
University of Cape Town, South Africa Sanofi-Aventis Speaker's Bureau
Shah, Sarita Centers for Disease Control and Prevention None N/A
Sterling, Timothy Vanderbilt University Otsuka DSMB Member
Sanofi Consultant

* Group lead

Note: Members were asked to disclose all relationships from 24 months prior to the updated date. The period of reporting was from September 1, 2012, through September 1, 2014.

Download Guidelines